Tolfenamic acid    (DrugBank: Tolfenamic acid)

1 disease
IDDisease name (Link within this page)Number of trials
5Progressive supranuclear palsy1

5. Progressive supranuclear palsy    [ 82 clinical trials,   107 drugs,   (DrugBank: 36 drugs),   60 drug target genes,   90 drug target pathways]
Searched query = "Progressive supranuclear palsy", "PSP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 82 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04253132
(ClinicalTrials.gov)
January 1, 202117/12/2019Evaluation of Tolfenamic Acid in Individuals With PSP at 12-WeeksA Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Tolfenamic Acid for the Treatment of Progressive Supranuclear PalsyProgressive Supranuclear PalsyDrug: Tolfenamic Acid;Drug: PlacebosNeuroTau, Inc.The Cleveland ClinicNot yet recruiting40 Years85 YearsAll24Phase 1;Phase 2United States